The effect of oral indomethacin on psoriasis treated with the Ingram regime.
Fifty patients with psoriasis undergoing a standard Ingram regime were entered into a double-blind comparison of oral indomethacin and placebo. No significant differences were observed between the two groups in respect of disease activity or dithranol tolerance after 6 weeks.
Sheehan-Dare
R A
RA
Department of Dermatology, General Infirmary, Leeds, U.K.
Goodfield
M J
MJ
Rowell
N R
NR
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000875:Anthralin / Q000627:therapeutic use; D002908:Chronic Disease; D003033:Coal Tar / Q000627:therapeutic use; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology; D014467:Ultraviolet Therapy
D003033:Coal Tar; D000875:Anthralin; D007213:Indomethacin